Fundamental Global Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
Continued Growth in Reinsurance and Investment Results leads to Net Income in 2023 MOORESVILLE, N.C.–(BUSINESS WIRE)–Fundamental Global Inc. (Nasdaq:... Read more.
Forge Global Appoints Capital Markets Veteran Larry Leibowitz to its Board of Directors
SAN FRANCISCO–(BUSINESS WIRE)–Forge Global Holdings, Inc. (NYSE: FRGE) (“Forge”), a global private securities marketplace, announced today the appointment... Read more.
Virgin Galactic Reports Inducement Awards Under NYSE Listing Rule 303A.08
ORANGE COUNTY, Calif.–(BUSINESS WIRE)–Virgin Galactic Holdings, Inc. (NYSE: SPCE) (“Virgin Galactic”) announced that the Compensation Committee of... Read more.
Acacia Research Reports Fourth Quarter 2023 Financial Results
Intellectual Property Licensing and Settlement Agreements Drive Q4 Income; Company Continues to Advance Capital Allocation and Business Strategy, Announced Agreement... Read more.
Spruce Power Reports Fourth Quarter and Full-Year 2023 Results
DENVER–(BUSINESS WIRE)–Spruce Power Holding Corporation (NYSE: SPRU) (“Spruce” or the “Company”), a leading owner and operator of distributed... Read more.
Nuvation Bio Doses First Patient in Phase 1/2 Study of NUV-1511 for the Treatment of Advanced Solid Tumors
NUV-1511 is the Company’s first drug-drug conjugate (DDC) to enter the clinic NEW YORK–(BUSINESS WIRE)–Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical... Read more.
Glancy Prongay & Murray LLP Announces Investigation of Tempest Therapeutics, Inc. (TPST)
NEW YORK–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”) announces its investigation of Tempest Therapeutics, Inc. (Nasdaq: TPST) concerning... Read more.
Geron Announces FDA Oncologic Drugs Advisory Committee Votes in Favor of the Clinical Benefit/Risk Profile of Imetelstat for the Treatment of Transfusion-Dependent Anemia in Patients with Lower-Risk MDS
FDA Oncologic Drugs Advisory Committee voted 12 to 2 in favor of the clinical benefit/risk profile of imetelstat based on results from the IMerge Phase 3 clinical... Read more.
Spruce Biosciences, Inc. (SPRB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
NEW YORK–(BUSINESS WIRE)–$SPRB #classaction–Attorney Advertising–Bronstein, Gewirtz & Grossman, LLC is investigating potential claims... Read more.
TCW Global Real Estate Fund Recognized in 2024 LSEG Lipper Awards
LOS ANGELES–(BUSINESS WIRE)–The TCW Group, a leading global asset management firm, announced today that its TCW Global Real Estate Fund (TGREX) was honored... Read more.